Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Nov;8(4):575-590.
doi: 10.15171/apb.2018.066. Epub 2018 Nov 29.

A Review of Herbal Therapy in Multiple Sclerosis

Affiliations
Review

A Review of Herbal Therapy in Multiple Sclerosis

Sina Mojaverrostami et al. Adv Pharm Bull. 2018 Nov.

Abstract

Multiple sclerosis is a complex autoimmune disorder which characterized by demyelination and axonal loss in the central nervous system (CNS). Several evidences indicate that some new drugs and stem cell therapy have opened a new horizon for multiple sclerosis treatment, but current therapies are partially effective or not safe in the long term. Recently, herbal therapies represent a promising therapeutic approach for multiple sclerosis disease. Here, we consider the potential benefits of some herbal compounds on different aspects of multiple sclerosis disease. The medicinal plants and their derivatives; Ginkgo biloba, Zingiber officinale, Curcuma longa, Hypericum perforatum, Valeriana officinalis, Vaccinium macrocarpon, Nigella sativa,Piper methysticum, Crocus sativus, Panax ginseng, Boswellia papyrifera, Vitis vinifera, Gastrodia elata, Camellia sinensis, Oenothera biennis, MS14 and Cannabis sativa have been informed to have several therapeutic effects in MS patients.

Keywords: Demyelination; Herbal therapy; Inflammation; Multiple sclerosis; Remyelination.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Camina-Tato M, Fernandez M, Morcillo-Suarez C, Navarro A, Julia E, Edo MC. et al. Genetic association of CASP8 polymorphisms with primary progressive multiple sclerosis. J Neuroimmunol. 2010;222(1-2):70–5. doi: 10.1016/j.jneuroim.2010.03.003. - DOI - PubMed
    1. Hasan KM, Walimuni IS, Abid H, Datta S, Wolinsky JS, Narayana PA. Human brain atlas-based multimodal MRI analysis of volumetry, diffusimetry, relaxometry and lesion distribution in multiple sclerosis patients and healthy adult controls: Implications for understanding the pathogenesis of multiple sclerosis and consolidation of quantitative MRI results in MS. J Neurol Sci. 2012;313(1-2):99–109. doi: 10.1016/j.jns.2011.09.015. - DOI - PMC - PubMed
    1. Franklin RJ, Ffrench-Constant C. Remyelination in the CNS: From biology to therapy. Nat Rev Neurosci. 2008;9(11):839–55. doi: 10.1038/nrn2480. - DOI - PubMed
    1. Fancy SP, Kotter MR, Harrington EP, Huang JK, Zhao C, Rowitch DH. et al. Overcoming remyelination failure in multiple sclerosis and other myelin disorders. Exp Neurol. 2010;225(1):18–23. doi: 10.1016/j.expneurol.2009.12.020. - DOI - PubMed
    1. Franklin RJ, Kotter MR. The biology of CNS remyelination: The key to therapeutic advances. J Neurol. 2008;255 Suppl 1:19–25. doi: 10.1007/s00415-008-1004-6. - DOI - PubMed

LinkOut - more resources